Aerium Therapeutics
Boston
About Aerium Therapeutics
Aerium Therapeutics is discovering and developing novel monoclonal antibodies (mAbs) and antiviral treatments against SARS-CoV-2 variants.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2022)
- Website: aeriumtx.com
- Phone: [email protected]
Industries & Categories
Biopharma, Health Care, Medical, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/aerium-therapeutics-3486257 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.